FP7H2020HORIZON
Stichting Biomedical Primate Research Center
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 26
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 23,299,954
- Active
- 2009 to 2024
Projects
26 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| Host4HypnozoitesParasite-host interactions regulating dormancy and reactivation of malaria parasites | HORIZON | 2024 | Participant | EUR 5,800,000 |
| TBVAC-HORIZONImproving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity | HORIZON | 2023 | Participant | EUR 900,000 |
| TDVisionDetailed Cortical Mechanisms of Top-Down Visual Processing | HORIZON | 2023 | Participant | EUR 600,000 |
| CAPTIVATECorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies | HORIZON | 2023 | Participant | EUR 1,317,595 |
| ISIDOReIntegrated Services for Infectious Disease Outbreak Research | HORIZON | 2022 | Participant | EUR 1,032,971 |
| TRANSVAC-DSDESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE | H2020 | 2020 | Participant | EUR 52,206 |
| TRANSVAC2European Vaccine Research and Development Infrastructure | H2020 | 2017 | Participant | EUR 2,576,814 |
| HONOURsHost switching pathogens, infectious outbreaks and zoonosis; a Marie Sklodowska-Curie Training Network | H2020 | 2017 | Participant | EUR 255,374 |
| RABYD-VAXDevelopment of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine | H2020 | 2017 | Participant | EUR 818,459 |
| VAC2VACVaccine lot to Vaccine lot comparison by consistency testing. | H2020 | 2016 | Participant | EUR 305,090 |
| EHVAEuropean HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | H2020 | 2016 | Participant | EUR 1,000,018 |
| TBVAC2020TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development | H2020 | 2015 | Participant | EUR 918,195 |
| FLUCOPStandardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection | FP7 | 2015 | Participant | EUR 130,000 |
| PRIMOMEDUse of PRIMate MOdels to support translational MEDicine and advance disease modifying therapies for unmet medical needs | FP7 | 2014 | Participant | EUR 6,000 |
| SYSMALVACIdentifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria | FP7 | 2013 | Participant | EUR 276,975 |
| EDUFLUVACCombinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure | FP7 | 2013 | Participant | EUR 983,670 |
| TRIADTolerance Restoration In Autoimmune Diseases by selective manipulation of the CD28 costimulatory pathway | FP7 | 2012 | Participant | EUR 444,571 |
| EUPRIM-NET IIEuropean Primate Network: Advancing 3Rs and International Standards in Biological and Biomedical Research | FP7 | 2011 | Participant | EUR 2,697,430 |
| WINGSWest Nile Integrated Shield Project: Epidemiology, Diagnosis and Prevention of West Nile Virus in Europe | FP7 | 2011 | Participant | EUR 508,136 |
| NEWTBVACDiscovery and preclinical development of new generation tuberculosis vaccines | FP7 | 2010 | Participant | EUR 778,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.